- Home
- ADVM vs PVL Comparison
ADVM vs PVL Comparison
Compare ADVM & PVL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ADVM
- PVL
- Stock Information
- Founded
- ADVM 2006
- PVL 2011
- Country
- ADVM United States
- PVL United States
- Employees
- ADVM N/A
- PVL N/A
- Industry
- ADVM Biotechnology: Biological Products (No Diagnostic Substances)
- PVL Oil & Gas Production
- Sector
- ADVM Health Care
- PVL Energy
- Exchange
- ADVM Nasdaq
- PVL Nasdaq
- Market Cap
- ADVM 47.4M
- PVL 60.7M
- IPO Year
- ADVM 2014
- PVL N/A
- Fundamental
- Price
- ADVM $2.39
- PVL $1.80
- Analyst Decision
- ADVM Strong Buy
- PVL
- Analyst Count
- ADVM 5
- PVL 0
- Target Price
- ADVM $23.80
- PVL N/A
- AVG Volume (30 Days)
- ADVM 133.0K
- PVL 46.8K
- Earning Date
- ADVM 08-11-2025
- PVL 01-01-0001
- Dividend Yield
- ADVM N/A
- PVL 5.25%
- EPS Growth
- ADVM N/A
- PVL N/A
- EPS
- ADVM N/A
- PVL 0.09
- Revenue
- ADVM $1,000,000.00
- PVL $4,344,009.00
- Revenue This Year
- ADVM N/A
- PVL N/A
- Revenue Next Year
- ADVM $18.82
- PVL N/A
- P/E Ratio
- ADVM N/A
- PVL $21.05
- Revenue Growth
- ADVM N/A
- PVL N/A
- 52 Week Low
- ADVM $1.78
- PVL $1.30
- 52 Week High
- ADVM $8.56
- PVL $2.00
- Technical
- Relative Strength Index (RSI)
- ADVM 42.53
- PVL 50.91
- Support Level
- ADVM $2.61
- PVL $1.68
- Resistance Level
- ADVM $2.82
- PVL $1.81
- Average True Range (ATR)
- ADVM 0.21
- PVL 0.05
- MACD
- ADVM -0.02
- PVL -0.00
- Stochastic Oscillator
- ADVM 3.20
- PVL 66.67
About ADVM Adverum Biotechnologies Inc.
Adverum Biotechnologies Inc is a clinical-stage company that aims to establish gene therapy as a new standard of care for prevalent ocular diseases. It develops gene therapy product candidates intended to provide durable efficacy by inducing sustained expression of a therapeutic protein. Its product candidate, ixoberogene soroparvovec (Ixo-vec), is a single, in-office intravitreal (IVT) injection gene therapy product designed to deliver long-term durable therapeutic levels of aflibercept associated with a robust, sustained treatment response, reducing the treatment burden and fluctuations in macular fluid associated with bolus anti-vascular endothelial growth factor (VEGF) IVT injections.
About PVL Permianville Royalty Trust Trust Units
Permianville Royalty Trust is a statutory trust which holds net profits interests in the profits from the sale of oil and natural gas production the sale of oil and natural gas production from primarily non-operated assets of both conventional properties in the States of Texas, Louisiana, and New Mexico as well as unconventional assets in the Permian and Haynesville basins.